Trial of Parkinson's And Zoledronic Acid
NCT03924414
Atypical Parkinsonism, Autonomic Nervous System Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT Number: NCT05889260
The goal of the Speech Accessibility Project at the University of Illinois Beckman Institute (https://speechaccessibilityproject.beckman.illinois.edu) is to collect, annotate, and curate a shared database of speech samples from people with atypical speech, and share this data set with researchers at other organizations. This two-year project plans to collect 1,200,000 speech samples from 2,000 people, each of whom will provide 600 samples. In Year 1, the initial focus will be people with Parkinson's. In Year 2, four more etiologies of interest will be recruited: Amyotrophic Lateral Sclerosis (ALS), Cerebral Palsy (CP), Down Syndrome (DS), and Stroke. UIUC will build an open-source software infrastructure to collect annotated speech samples and share these data in an appropriately secure fashion with researchers from our partner technology companies (and eventually, other organizations as well) so that they can use these data to improve their automatic speech recognition algorithms. This project promotes diversity, equity, and inclusion by helping technology companies to fully support all types of speech, and it is also more efficient and less burdensome for these specialized patient populations to have one centralized "collector" of speech samples.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
LSVT Global, Denver, Colorado, United States
The goal of our project is to collect 1,200,000 speech samples from 2,000 people with dysarthria, where we expect to collect data from 400 people each from five different patient populations. Each person would provide 600 speech samples.
(600 samples/person x 400 persons/etiology x 5 etiologies = 1,200,000 samples)
Our schedule of research procedures is:
Data collection of speech samples in Year 1 will be a collaboration of the University of Illinois and of mentors from Lee Silverman Voice Therapy (LSVT) Global. Potential participants will be screened both with a questionnaire and by providing a short set of "quality control" speech samples. If the participant does not pass screening, they will be thanked for their interest. Otherwise, the participant is eligible for the study and can do the informed consent process and then engage in contributing speech samples.
Participants can do as many recordings as they wish at whatever time of day is convenient for them. Participants will be able to login to the system at any time, 24/7.
In Year 2, this procedure will be performed with patients from other etiologies with additional advocacy organizations as partners.
Participants who are unable to read text from the computer screen will be offered the opportunity to record speech using a verbal-repetition protocol. In order to participate in the verbal repetition protocol, a participant must be accompanied by a caregiver who is also willing to be recorded. If a participant agrees to this protocol, then the caregiver will read each prompt to the participant. The participant will then repeat the words spoken by the caregiver, or respond to any question asked by the caregiver.
Participants also have the option to provide additional data about themselves, such as their age, race and ethnicity, and the year of their diagnosis. These "metadata tags" are completely optional but are helpful for analysis.
The collected speech samples will be stored securely in a custom database built by the UIUC Beckman Institute. All samples are stored with a unique participant ID code. All samples are annotated by our UIUC research team with technical information about the acoustic waveform and other information.
The entire database of speech samples will be shared with our coalition partners (Amazon, Apple, Google, Meta, and Microsoft), and, after all data collection is complete, with other universities and companies who are willing to sign our data use agreement. Each partner has signed a data use agreement with UIUC that allows these deidentified data to be used for improvements in speech recognition technology and assures the privacy of participants and confidentiality of data.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3-7 hours, self-paced
Each participant records 600 sentences: 480 read sentences, and 120 spontaneous sentences recorded in response to 30 prompts.
University of Illinois at Urbana-Champaign
Other
People With Speech Disabilities Contributing Speech Samples for Improved Accessibility of Speech-Enabled Devices
Acronym: SAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03924414
Atypical Parkinsonism, Autonomic Nervous System Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT04518059
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT05067192
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Lund, Skåne County, Sweden
View Trial DetailsNCT05222386
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Rochester, New York, United States
View Trial Details